Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Treatments for Inflammatory Punctal Stenosis
NCT06798025Completed
- Sponsor
- Tanta University
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of triamcinolone in inflammatory punctal stenosis (3 arms), sponsored by Tanta University. Primary endpoint: Degree of patient satisfaction at 3 months. Started Jul 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
inflammatory punctal stenosis
Beyond the preview
Go deeper on NCT06798025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798025.